UCSF and UCSF Health Receive Pivotal Donation to Support the First Continuous AI-monitoring Platform in Clinical Care

The UCSF Division of Clinical Informatics and Digital Transformation (DoC-IT) and UCSF Health have received a $5 million gift from Ken and Kathy Hao to develop a cutting-edge, real-time, continuous, and automated artificial intelligence (AI) monitoring platform for clinical care. 

The Impact Monitoring Platform for AI in Clinical Care (IMPACC) aims to bridge the gap between the rapid evolution of AI technologies used by clinicians and the essential need for robust, ongoing assessment of their efficacy, safety, and equity. 


Julia Adler-Milstein, PhD, chief of the UCSF Division of Clinical Informatics and Digital Transformation (DoC-IT), and Sara Murray, MD, MAS, chief health AI officer at UCSF Health, will lead the pioneering collaboration.


“This philanthropic gift is transformative in many ways,” said Adler-Milstein. “It comes at a critical juncture as the healthcare industry more broadly integrates AI into clinical practice. Through IMPACC and this collaborative effort, we are poised to improve patient care at UCSF while advancing the science of how to assess AI tools in real-world use.”


Currently, the healthcare field lacks established protocols for ongoing AI monitoring, leading to risks of adverse outcomes for patients and healthcare providers that go undetected. While assessments are conducted to determine the suitability of new AI technologies for safe integration into clinical environments before deployment, once they are deployed, health systems need a way to promptly identify any issues in their real-world performance.

IMPACC will fill this urgent need by shifting from planned, periodic, manual monitoring of a focused set of measures to real-time, continuous, automated, and longitudinal monitoring across a broad measure set with specified criteria for escalation to human review and intervention.



Full Article:  https://docit.ucsf.edu/news/ucsf-and-ucsf-health-receive-pivotal-donation-support-first-continuous-ai-monitoring-platform

The body content of your post goes here. To edit this text, click on it and delete this default text and start typing your own or paste your own from a different source.

Share this Article with others

December 6, 2025
Press Release November 2025: Oracle and Ci4CC Partner to Accelerate Oncology Innovation Strategic collaboration to leverage Ci4CC’s national network and Oracle’s technology to help advance AI in oncology, EHR interoperability, next-gen clinical trials, and personalized medicine 24th Cancer Center Informatics Society Symposium - MIAMI BEACH, Florida – November 7, 2025 – Oracle Health and Life Sciences and the Cancer Center Informatics Society (Ci4CC), a nonprofit uniting cancer centers, researchers, and industry innovators, are collaborating to advance AI innovation in oncology care and research. The collaboration aims to bring together Oracle’s technology with Ci4CC’s Initiatives Program and national network of NCI-Designated and Community Care Cancer Centers. The two organizations plan to collaborate to design an EHR optimized for cancer care. “Cancer remains a leading cause of death worldwide, but AI and data science have become powerful allies in the fight,” said Seema Verma, executive vice president and general manager, Oracle Health and Life Sciences. “Combining Ci4CC’s unparalleled expertise and network with our state-of-the-art proven AI-powered healthcare applications, we have the opportunity to accelerate discoveries that can help cure cancer.” The strategic collaboration intends to develop initiatives across oncology care and clinical research. This includes integrating clinical and genomic data for personalized medicine solutions, pioneering AI-driven approaches for clinical trial innovation and drug development, establishing robust real-world evidence frameworks, and advancing precision oncology platforms. “This alliance with Oracle marks a significant milestone for Ci4CC and our mission to further cancer informatics,” said Sorena Nadaf-Rahrov, MS, MMI, PhDc, President & CEO - Cancer Center Informatics Society. “Advancements in cancer research and clinical care are not achieved in isolation. That’s why fostering such collaborative networks is fundamental to our Initiatives Program, and central to the Society’s mission. By integrating Oracle’s cutting-edge and AI-enabled technology with real-world data from our national network of NCI-Designated and Community Cancer Centers, we hope to incubate and operationalize initiatives that will redefine cancer research and patient care. Turning data into knowledge, and knowledge into health continues to drive the Cancer Center Informatics Society forward.” Oracle NewsRoom: https://www.oracle.com/news/announcement/oracle-and-ci4cc-partner-to-accelerate-oncology-innovation-2025-11-07/ PR Newswire: https://www.prnewswire.com/news-releases/oracle-and-ci4cc-partner-to-accelerate-oncology-innovation-302608712.html
July 3, 2025
Tool aims to solve the mystery of non-coding sequences — but is still in its infancy.
By Sorena Nadaf June 6, 2025
Cancer Center Informatics Society Working Group Announcement and Endorsement of the American Center for Cures
By Sorena Nadaf April 17, 2025
Caught in the crossfire: The critical threats facing cancer centers, research, and patient care. Shannon McWeeney PhD, & Sorena Nadaf-Rahrov MS, MMI
By Sorena Nadaf February 13, 2025
January 2025 Newsletter: The Year of Artificial Intelligence Sorena Nadaf-Rahrov, MS, MMI, PhDc
By Sorena Nadaf February 5, 2025
A recent Lancet study demonstrated that AI implementation led to a 29% increase in cancer detection, with no increase in false positives and a reduced workload compared to radiologists without AI assistance. While emerging evidence supports AI’s potential to enhance cancer detection in mammography screening and reduce screen-reading workload, further research is needed to fully understand its clinical impact.
By Sorena Nadaf December 10, 2024
Artificial intelligence to empower diagnosis of myelodysplastic syndromes by multiparametric flow cytometry
By Sorena Nadaf November 11, 2024
With heavy hearts, we remember and honor Brady Davis, whose sudden passing leaves an immense void. Brady was a devoted supporter and invaluable contributor to the Cancer Center Informatics Society, dedicating countless hours to advancing our mission and strengthening our community. His expertise, enthusiasm, and unwavering commitment shaped our initiatives and inspired everyone fortunate enough to work alongside him. Brady’s legacy will live on through the progress he championed and the connections he fostered. We extend our deepest sympathies to his family, friends, and all who knew him. He will be greatly missed. In honor of Brady’s legacy, Ci4CC will be forming a committee to explore meaningful ways to memorialize him within our society for years to come. We plan to announce the committee’s recommendations at our Spring Summit in San Diego, CA, on March 31, 2025. Please find his obituary here , and visit his memorial page on MyKeeper to leave a tribute. Support the Davis family in Brady’s memory via GoFundMe ---------- Cancer Center Informatics Society (Ci4CC) Sorena Nadaf-Rahrov & Warren Kibbe Co-Founders, Ci4CC
By Sorena Nadaf October 29, 2024
Nature Digital Medicine PRISM: Patient Records Interpretation for Semantic clinical trial Matching system using large language models